The Ohio Codes website is experiencing system issues with the Ohio Administrative Code. While we are working to resolve the issue as quickly as possible, filed versions of individual Ohio Administrative Code rules can be accessed by entering the rule number in the "Rule Number Quick Search" box on the Register of Ohio. Thank you for your patience.

Rule 4729:8-2-02 | Additional drugs to be reported.

Ohio Administrative Code

4729:8

Chapter 4729:8-2 | Drugs Required to be Reported to Ohio Automated Rx Reporting System (OARRS)

Effective:

March 15, 2019

Promulgated Under:

119.03

PDF:

Download Authenticated PDF

(A) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription, personally furnished by a prescriber, or sold at wholesale to a prescriber or terminal distributor of dangerous drugs shall be submitted to the state board of pharmacy in accordance with sections 4729.77, 4729.78 and 4729.79 of the Revised Code and this division of the Administrative Code:

All dangerous drug products containing gabapentin.

(B) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription shall be submitted to the state board of pharmacy in accordance with section 4729.77 of the Revised Code and this division of the Administrative Code:

All dangerous drug products containing naltrexone that are indicated for the treatment of alcohol dependence or the prevention of relapse to opioid dependence.

Last updated September 11, 2023 at 11:40 AM

Supplemental Information

Authorized By: 4729.84, 4729.26, 3719.28
Amplifies: 4729.75, 4729.84, 4729.83, 4729.82, 4729.81, 4729.80, 4729.79, 4729.78, 4729.77, 4729.76
Five Year Review Date: 9/11/2024
Prior Effective Dates: 12/1/2016